Market News How it works Learn FAQ
| AXG 0.0378 -29.74% | SHFS 0.1113 18.40% | DVLT 0.069 -48.04% | XXII 0.1022 15.61% | NEXR 0.5454 21.77% | SOFI 16.4 13.42% | WFF 0.0601 -33.07% | NU 12.4 -1.51% | NVD 3.93 -1.50% | SPCX 148.58 1.14% | SOXL 101.08 11.69% | EWZ 34.3 0.45% | INTC 93.74 3.61% | NVDA 217.94 0.90% | BBD 2.91 -0.51% | SOXS 42.495 -11.43% | JBLU 2.82 18.99% | GRAB 2.72 0.37% | GPUS 0.2126 19.10% | VALE 11.84 -1.33% | SNTI 0.1867 6.62% | NOK 8.89 3.30% | HYG 77.6 0.52% | AAL 12.61 3.36% | BITO 10.79 1.27% | CRWV 59.57 7.94% | TSLL 11.63 8.09% | RCT 0.0632 -23.58% | META 620.19 -1.64% | TQQQ 71.05 3.83% | QID 13.86 -2.53% | STLA 4.14 1.47% | NFLX 62.52 -2.16% | TSLG 5.82 8.18% | BA 168.18 -10.69% | IREN 27.44 7.90% | T 20.94 0.46% | PLUG 1.4 2.19% | BRAI 3.31 56.13% | TSLA 407.46 4.04% | CIFR 8.48 9.99% | ONDS 6.65 7.95% | RWM 14.34 -1.10% | F 11.71 1.12% | RIG 6.46 -1.07% | XP 15.96 1.62% | ITUB 7.67 -0.39% | SNAP 6.06 -4.42% | KORU 11.85 8.82% | WULF 12.66 5.68%
BGBGM Group Ltd. logo

BGM Group Ltd. (BGM)

NASDAQ Global Market · Currency in USD
$8.98 ▲ +0.58 (+6.85%)
At close: Oct 27, 4:00 PM ET. Market closed.
$9.15 ▲ +0.18 (+1.95%)
After hours: Oct 27, 4:10 PM ET

Summary

Previous Close
$8.40
Open
$8.55
Day's Range
$8.55 – $8.98
52 Week Range
$6.45 – $302.40
Volume
2,748
Avg. Volume
8,843
Market Cap
$113.87M
Beta (5Y Monthly)
1.87
PE Ratio (TTM)
--
EPS (TTM)
-$3.42
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
Feb 27, 2023
1y Target Est
--

Profile: BGM Group Ltd.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
298
CEO
Chen Xin

Operating from Chengdu, People's Republic of China, BGM Group Ltd. engages in the manufacturing and supply of active pharmaceutical ingredients (APIs), traditional Chinese medicine (TCM) derivatives, and various other related products across China. The company's pharmaceutical portfolio includes an array of licorice-based items: Gan Di Xin, an oral medication for cough and expectorant relief; Qilian Shan Licorice Extract, serving as a raw material for pharmaceutical firms to produce conventional licorice tablets; and Qilian Shan licorice liquid extract, a key ingredient utilized by medical preparers for crafting compound licorice oral solutions. BGM also provides Qilian Shan oxytetracycline tablets, formulated to prevent and treat a range of ailments in poultry (chickens, turkeys), livestock (cattle, swine), and humans, in addition to Qilian Shan oxytetracycline APIs for use by pharmaceutical manufacturers.

Earnings

DateEst.Actual
May 15, 2024–$0.05

Get free alerts on BGM and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.